Dr. Georgia Malandraki, PhD

Claim this profile
Studies Stroke
Studies Parkinson's Disease
1 reported clinical trial
1 drug studied

Area of expertise

1Stroke
Georgia Malandraki, PhD has run 1 trial for Stroke. Some of their research focus areas include:
Stage II
Stage III
Stage IV
2Parkinson's Disease
Georgia Malandraki, PhD has run 1 trial for Parkinson's Disease. Some of their research focus areas include:
Stage II
Stage III
Stage IV

More about Georgia Malandraki, PhD

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Georgia Malandraki, PhD has experience with
  • SEMG-biofeedback

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Georgia Malandraki, PhD specialize in?
Georgia Malandraki, PhD focuses on Stroke and Parkinson's Disease. In particular, much of their work with Stroke has involved Stage II patients, or patients who are Stage III.
Is Georgia Malandraki, PhD currently recruiting for clinical trials?
No, Georgia Malandraki, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Georgia Malandraki, PhD has studied deeply?
Yes, Georgia Malandraki, PhD has studied treatments such as sEMG-biofeedback.
What is the best way to schedule an appointment with Georgia Malandraki, PhD?
Apply for one of the trials that Georgia Malandraki, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.